Mitchell Stephen Ray 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Mitchell Stephen Ray
Director
Transactions
- Sale
Common Stock
2025-06-13$4.59/sh−7,000$32,130→ 97,082 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.58 to $4.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.